home / stock / akca / akca quote
Last: | $18.17 |
---|---|
Change Percent: | 0.17% |
Open: | $18.15 |
Close: | $18.17 |
High: | $18.17 |
Low: | $18.13 |
Volume: | 813,044 |
Last Trade Date Time: | 10/09/2020 04:44:24 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$18.17 | $18.15 | $18.17 | $18.17 | $18.13 | 813,044 | 10-09-2020 |
$18.14 | $18.15 | $18.14 | $18.15 | $18.13 | 268,638 | 10-08-2020 |
$18.13 | $18.14 | $18.13 | $18.15 | $18.13 | 787,483 | 10-07-2020 |
$18.13 | $18.13 | $18.13 | $18.14 | $18.1 | 203,153 | 10-06-2020 |
$18.14 | $18.13 | $18.14 | $18.16 | $18.08 | 947,907 | 10-05-2020 |
$18.13 | $18.08 | $18.13 | $18.17 | $18.08 | 285,147 | 10-02-2020 |
$18.14 | $18.13 | $18.14 | $18.15 | $18.11 | 448,227 | 10-01-2020 |
$18.14 | $18.13 | $18.14 | $18.155 | $18.12 | 720,161 | 09-30-2020 |
$18.14 | $18.14 | $18.14 | $18.15 | $18.13 | 250,752 | 09-29-2020 |
$18.14 | $18.14 | $18.14 | $18.17 | $18.125 | 657,097 | 09-25-2020 |
$18.14 | $18.14 | $18.14 | $18.21 | $18.12 | 378,655 | 09-24-2020 |
$18.14 | $18.14 | $18.14 | $18.18 | $18.14 | 1,489,109 | 09-23-2020 |
$18.14 | $18.12 | $18.14 | $18.2 | $18.12 | 1,264,619 | 09-22-2020 |
$18.14 | $18.1 | $18.14 | $18.15 | $18.05 | 550,984 | 09-21-2020 |
$18.15 | $18.12 | $18.15 | $18.21 | $18.12 | 950,498 | 09-18-2020 |
$18.14 | $18.14 | $18.14 | $18.16 | $18.13 | 903,962 | 09-17-2020 |
$18.14 | $18.15 | $18.14 | $18.16 | $18.14 | 408,761 | 09-16-2020 |
$18.13 | $18.13 | $18.13 | $18.175 | $18.13 | 769,801 | 09-15-2020 |
$18.12 | $18.14 | $18.12 | $18.16 | $18.07 | 820,941 | 09-14-2020 |
$18.14 | $18.15 | $18.14 | $18.16 | $18.11 | 497,187 | 09-11-2020 |
News, Short Squeeze, Breakout and More Instantly...
Akcea Therapeutics Inc. Company Name:
AKCA Stock Symbol:
NASDAQ Market:
Akcea Therapeutics Inc. Website:
Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif. , Oct. 30, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, In...
Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more efficient company PR Newswire CARLSBAD, Calif., Oct. 12, 2020 CARLSBAD, Calif. , Oct. 12, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS...
NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc. (NASDAQ: AKCA ), relating...